Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Semin Arthritis Rheum. 2021 Jun 15;51(4):853–857. doi: 10.1016/j.semarthrit.2021.06.003

Table 2.

Treatment characteristics of the 897 incident RA by decade of index date

Characteristic 1980s 1990s 2000s
ESR at index, mm/hr, median (IQR) 25 (31,40) 20 (8,34) 18 (9,32)
Max ESR first year, mm/hr, median (IQR) 36 (20,50) 27 (12,42) 23 (12,40)
Methotrexate use in first year, N (%) 4 (2) 83 (28) 233 (58)
Hydroxychloroquine use in first year, N (%) 50 (25) 133 (45) 225 (56)
Other csDMARD use in first year, N (%) 56 (28) 44 (15) 37 (9)
Biologic DMARD use, N (%) 0 (0) 1 (0) 39 (9)

cs = conventional synthetic, DMARD = disease-modifying anti-rheumatic drug, ESR = erythrocyte sedimentation rate, IQR = interquartile range, RA = rheumatoid arthritis